TimeTech Dividend Policy, Buybacks and Capital-Return Gates
Strategic-level simulation · From dividend theory and policy calculations through the cash bridge, buybacks, share instruments and listed-company governance
A strategic-level simulation on teaching scenario: as TimeTech's Finance Manager, following the company's strategic financing and stock-market listing, you compare four dividend policies alongside cash dividends, share buybacks, stock dividends and stock splits, then shape a low regular dividend plus a conditional additional return, governed by cash, solvency, covenant, audit, approval and market-rule gates.
The question
The 2028 net profit was $15 million, there are currently 100 million ordinary shares in issue, and basic earnings per share is $0.15. The 2029 growth investment requirement is $12 million, with a target financing structure of 40% debt and 60% equity; the equity funding required for the investment is $7.2 million.
Company background
TimeTech Ltd. develops, manufactures and sells smart wearable devices and provides online health-management services. This course uses a fictional future case timeline: the company has completed its 2027 strategic financing and its 2028 stock-market listing, and it now needs to establish a sustainable capital-return policy that balances growth investment, debt service and liquidity, shareholder returns and listed-company governance.
Techniques
股利理论、政策计算与事实边界投资、现金、偿债与压力治理资本返还工具与市场影响分配程序、合规与实施闸门取证与董事会沟通Who it suits
Suited to learners who already grasp the fundamentals of F3 dividend theory, capital structure and shareholder value and are preparing for the Strategic level , with an emphasis on profit-versus-cash boundaries, capital-return discipline, shareholder communication and board-level implementation governance.
All courses
- TimeTech Business Valuation and the Strategic Fundraising Gate
- TimeTech M&A Evaluation, Integration and Restructuring Gateways
- TimeTech Organisational Structure Design and Change Pilot
- TimeTech Mutually Exclusive Production Investment Decision
- TimeTech IPO Readiness, R&D Investment and Capital Allocation
- TimeTech T-100 Cost Diagnosis